News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor (World)
Argenx Release: Invitation To The Extraordinary Shareholders' Meeting 9/22/2017
Zealand Pharma  (ZEAL.CO) Increases Its Share Capital As A Consequence Of Exercise Of Employee Warrants 9/22/2017
Galapagos (GLPG.BR) Increases Share Capital Through Warrant Exercises 9/22/2017
DelMar Pharma Announces $10 Million Registered Direct Offering Priced At-The-Market 9/21/2017
Epigenomics AG Issues New Shares By Way Of Private Placement 9/21/2017
Capital Cell, Europe’s First Dedicated Life Sciences Crowdfunding Platform, Opens To UK Investors 9/20/2017
Nabriva (NBRV) Announces Pricing Of Public Offering Of Ordinary Shares Of Approximately $80 Million 9/20/2017
3 Of The Most Innovation-Forward Biotechs Right Now 9/19/2017
Is This The Best Oncology Play In The Market? 9/19/2017
Bristol-Myers Squibb (BMY) Stock Still A Beast? 9/19/2017
TiGenix Business And Financial Update For The First Half 2017 9/19/2017
MediWound (MDWD) Announces Pricing Of $22 Million Public Offering Of Ordinary Shares 9/19/2017
Summit Therapeutics Announces Closing Of Its ADS Public Offering Raising $20.1 Million Before Expenses 9/19/2017
Nabriva (NBRV) Announces Proposed Public Offering Of Ordinary Shares 9/19/2017
MediWound (MDWD) Announces Public Offering Of Ordinary Shares 9/19/2017
NOXXON Pharma AG Issues Second Tranche Of Odirnane Bonds 9/19/2017
Novo Nordisk A/S (NVO) - Share Repurchase Programme 9/18/2017
BiondVax Announces Closing Of $10 Million Public Offering Of American Depositary Shares And Exercise Of Over-Allotment Option 9/18/2017
Summit Therapeutics Announces Exercise Of Underwriters’ Over-Allotment Option 9/18/2017
OWC Pharmaceutical Research Corp. Issues Chairman's Letter To Shareholders 9/15/2017
Investors' Biggest Worry About GW Pharma (GWPH) Could Be The Biotech's Ace In The Hole 9/14/2017
BioAmber Receives Notice Of Non-Compliance From The NYSE 9/14/2017
BiondVax Announces Pricing Of Public Offering Of American Depositary Shares 9/14/2017
Report From Sectra (SECTB)'s 2017 Annual General Meeting And Timetable For Redemption Program To Transfer SEK 4.50 Per Share To Shareholders 9/14/2017
Bavarian Nordic (BAVA.CO) To Host Capital Markets Day In New York City 9/14/2017
Eisai Company (ESALY.PK) Selected For Fifth Consecutive Year Of Membership In Dow Jones Sustainability Asia Pacific Index 2017 9/14/2017
Summit Therapeutics Announces Proposed Public Offering Of $15.0 Million Of American Depositary Shares 9/14/2017
Summit Therapeutics Announces Pricing Of Public Offering Of 1,459,000 American Depositary Shares 9/14/2017
Summit Therapeutics Announces Underwritten Public Offering Of 1,459,000 ADSs To Raise USD17.5 Million Before Expenses 9/14/2017
Curis (CRIS) Announces Pricing Of Public Offering Of Common Stock 9/14/2017
Ablynx (ABLYF) Announces Warrant Exercise 9/14/2017
Imitator To Innovator: How China Could Soon Be The World's Tech Leader 9/13/2017
China Pharma Holdings (CPHI.OB) Announces Notification Of NYSE American Listing Deficiency 9/13/2017
Karolinska Development AB's Portfolio Company BioArctic Intends To List On Nasdaq Stockholm 9/13/2017
3 Dividend Superstars With Strong Growth Potential: GlaxoSmithKline (GSK), Pfizer (PFE), Sanofi (SNY) 9/12/2017
Bionik (BNKL) Postpones 2017 Annual Meeting Of Stockholders 9/12/2017
BriaCell Provides A Corporate Update 9/12/2017
GN Store Nord A/S (GN) Release: Transactions In Relation To Share Buyback Program 9/12/2017
Veloxis Pharma (VELO) Increases Share Capital In Connection With Exercise Of Warrants 9/12/2017
BioScience Managers Release: Medical Data Platform Charm Informatics Set For Commercial Launch After Investment By Biomedical Translation Fund 9/11/2017
Regeneus (RGS.AX) Edison Investment Report Issued 9/11/2017
Novo Nordisk A/S (NVO) - Share Repurchase Programme 9/11/2017
Marapharm Ventures Announces $4,633,348.00 Of Warrants Exercised 9/11/2017
Saluda Medical’s Spinal Cord Stimulation System Latest Investment For Biomedical Translation Fund 9/11/2017
Johnson & Johnson Medical Devices Companies Signals Commitment To Stroke Treatment With The Announcement Of New Neurovascular Business 9/7/2017
SGS (SGSN) Clinical Research Strengthens Its Consultancy Service To Accelerate Drugs Through Early Phase Development 9/7/2017
Tauriga (TAUG) Taking Immediate And Concrete Steps To Extinguish The Canadian Cease Trade Order Instituted By Autorite Des Marches Financiers (Quebec Based Regulatory Authority) 9/7/2017
Ingenza Invests In Faster Fermentation Development 9/6/2017
Jazz Pharma (JAZZ) Announces Completion Of Offering And Exercise In Full Of Initial Purchasers' Option To Purchase Additional 1.50% Exchangeable Senior Notes Due 2024 9/5/2017
Cellect (APOP) Shares Will Be Traded From Next Week Exclusively On NASDAQ 9/5/2017
CollPlant In Advanced Negotiations For US Private Placement Of USD 5.0 Million; Agreement Includes Plan For NASDAQ Uplisting 9/5/2017
Resverlogix (RVX.TO) Closes Extension Of Maturity Date Of Loan And Announces Private Placement 9/5/2017
Dechra - 20 Years Of Strategic Growth 9/5/2017
Novo Nordisk A/S (NVO): Share Repurchase Programme 9/5/2017
Report On Transactions With ALK-Abello A/S B-Shares And Associated Securities By Managerial Staff 9/5/2017
NicOx SA (COX.PA) : Number Of Voting Rights As Of August 31. 2017 9/5/2017
GN Store Nord A/S (GN) Release: Transactions In Relation To Share Buyback Program 9/5/2017
MorphoSys AG Presents Vision For Growth At Its Capital Markets Day 9/5/2017
Forward Pharma (FWP) Board Of Directors Approves Capital Reduction And Returns EUR 917.7 Million To Shareholders 9/1/2017
Zealand Pharma  (ZEAL.CO) Increases Its Share Capital As A Consequence Of Exercise Of Employee Warrants 9/1/2017
Dual-Listed BiondVax To Voluntarily Delist From Tel Aviv Stock Exchange 8/31/2017
Change Of Number Of Shares And Votes In Karolinska Development AB 8/31/2017
Total Number Of Shares And Voting Rights In Zealand Pharma  (ZEAL.CO) At August 31, 2017 8/31/2017
Report Reveals The Chinese Medical Device Market Growing Faster Than Pharma 8/30/2017
Alzheimer's Research UK Release: Leading Dementia Research Charity Welcomes Life Sciences Strategy 8/30/2017
Kamada (KMDA) Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares 8/30/2017
Ablynx (ABLYF) Release: Publication In Accordance With Article 14 Of The Belgian Law Of 2 May 2007 Regarding The Publication Of Major Shareholdings (The "Transparency Law") 8/30/2017
Targovax: Registration Of Share Capital Increase Following Exercise Of Employee Options And Settlement Of Restricted Stock Units 8/29/2017
GN Store Nord A/S (GN) Release: Transactions In Relation To Share Buyback Program 8/29/2017
Rhinomed Preliminary Final Report 8/29/2017
China Cord Blood Announces Adoption Of 10b5-1 Sales Plan 8/28/2017
Ossur (OSSR) : Transactions In Relation To Share Buyback Program 8/28/2017
Transactions With Shares And Linked Securities In H. Lundbeck A/S (LUN.CO) Made By Executives And Their Closely Associated Parties 8/28/2017
Novo Nordisk A/S (NVO) - Share Repurchase Programme 8/28/2017
Opiant Pharma Announces Listing On The Nasdaq Capital Market 8/28/2017
Delcath Systems (DCTH) Announces Agreement For Extinguishment Of Convertible Notes With Majority Holder 8/28/2017
Targovax: Mandatory Notification Of Trade By Primary Insider In Connection With Settlement Of RSUs 8/28/2017
Karolinska Development AB Notes The Planned Listing Of Xspray AB On Nasdaq First North 8/25/2017
Auris Med (EARS) Announces Receipt Of Nasdaq Notice 8/25/2017
Zealand Pharma  (ZEAL.CO) Grants New Warrants Under Employee Warrant Program 8/25/2017
Exercise Of Employee Share Options And Restricted Stock Units In Targovax 8/25/2017
NicOx SA (COX.PA) :Ordinary Shareholder Meeting On September 4, 2017 8/25/2017
Auris Med (EARS) Announces Receipt Of Nasdaq Notice 8/25/2017
5 Y Combinator Startups to Watch Out For 8/24/2017
AroCell AB: Interim Report, Q2 2017 8/24/2017
Macrophage Pharma Extends Series A Round To Include New Investor Merck Ventures 8/23/2017
Bavarian Nordic (BAVA.CO) Announces Major Shareholder Notification From Johnson & Johnson Innovation (JNJ) 8/23/2017
3 High-Yield Pharma Stocks To Put On Your Radar 8/22/2017
uniQure (QURE): A Busted Biotech IPO Worth Owning 8/22/2017
Intec Pharma Announces Closing Of $57.5 Million Public Offering Of Ordinary Shares 8/22/2017
Axovant (AXON) To Move Stock Exchange Listing To Nasdaq 8/22/2017
Bionik Laboratories Corp. (BNKL) Issues Letter To Shareholders 8/22/2017
GN Store Nord A/S (GN) Release: Transactions In Relation To Share Buyback Program 8/22/2017
The 5 Biotech-Pharma Stocks America's Biggest Hedge Funds Are Dropping 8/22/2017
Biohit - Managers' Transactions 8/22/2017
H. Lundbeck A/S (LUN.CO) Increases Its Share Capital By 470,889 Shares (0.2373 % Of Outstanding Shares) As A Result Of Exercise Of Employee Warrants 8/22/2017
Herantis Pharma's Manager's Transactions 8/22/2017
Bavarian Nordic (BAVA.CO) Announces Closing Of Transaction With Janssen Pharmaceutical And Issue Of Shares To Johnson & Johnson Innovation (JNJ) - JJDC 8/22/2017
Regeneus (RGS.AX) FY17 Results Announcement 8/22/2017
Innoviva Inc. (THRX) Completes Refinancing Of Its 9% 2029 Non-Recourse Notes 8/21/2017
Novo Nordisk A/S (NVO) - Share Repurchase Programme 8/21/2017
Verona Pharma (VRP.L) Release: PDMR Dealing 8/21/2017
Jazz Pharma (JAZZ) Announces Offering Of $500 Million Of 1.50% Exchangeable Senior Notes Due 2024 8/18/2017
Zealand Pharma  (ZEAL.CO) Release: Completion Of Exercise In Full Of Overallotment Option Of 15% 8/18/2017
3 Dividend Healthcare Stocks 8/17/2017
Trading In GN Store Nord A/S (GN) Shares By Board Members, Executives And Associated Persons On 17 August 2017 8/17/2017
Intec Pharma Announces Proposed Public Offering Of Ordinary Shares 8/16/2017
Intec Pharma Announces Pricing Of $50.0 Million Public Offering Of Ordinary Shares 8/16/2017
GN Store Nord A/S (GN) Release: Transactions In Relation To Share Buyback Program 8/15/2017
Capital Increase In Genmab A/S (GEN.CO) As A Result Of Employee Warrant Exercise 8/15/2017
Zealand Pharma  (ZEAL.CO) Release: Overallotment Option Of 15% Has Been Exercised 8/15/2017
Zealand Pharma  (ZEAL.CO) Release: End Of Stabilization Period 8/15/2017
Oxford Immunotec (OXFD) Announces Pricing Of Underwritten Public Offering Of Ordinary Shares 8/15/2017
Sinovac Biotech Ltd. (SVA) Announces Certain Updates Relating To Delayed Filing Of Annual Report On Form 20-F 8/14/2017
Trading In Novo Nordisk A/S (NVO) Shares By Board Members, Executives And Associated Persons On 11 August 2017 8/14/2017
Novo Nordisk A/S (NVO) - Share Repurchase Programme 8/14/2017
Zealand Pharma  (ZEAL.CO) Release: Completion Of The Initial Public Offering Of American Depositary Shares And Registration Of Capital Increase 8/14/2017
Ossur (OSSR) Initiates A New Share Buyback Program 8/14/2017
Ossur (OSSR) Share Buyback Program Completed 8/14/2017
2 Marijuana Stocks That Turned $10,000 Into $125,000 And $300,000, Respectively 8/11/2017
Ablynx (ABLYF) Announces Warrant Exercise 8/11/2017
Malin Corporation (MLC.IR) Investee Company - Melinta - To Be Transformed Into A NASDAQ Listed Company 8/10/2017
What Mylan (MYL) Has In Common With The Word Disaster 8/10/2017
Pharming Group (PHGUF.PK) Announces Cashless Warrant Exercises And Conversions Of Its Ordinary Bonds Into Shares 8/10/2017
Trading In Novo Nordisk A/S (NVO) Shares By Board Members, Executives And Associated Persons On 9 August 2017 8/10/2017
Transactions With Shares And Linked Securities In H. Lundbeck A/S (LUN.CO) Made By Executives And Their Closely Associated Parties 8/10/2017
Zealand Pharma  (ZEAL.CO) Publishes A Prospectus Regarding Listing Of 4,375,000 New Shares On Nasdaq Copenhagen As Part Of Its Issue Of American Depositary Shares Listed On The Nasdaq In The U.S. 8/10/2017
BeiGene (BGNE) Announces Proposed Public Offering 8/10/2017
Zealand Pharma  (ZEAL.CO) Prices Its Initial Public Offering Of American Depositary Shares On The Nasdaq Global Select Market In The United States 8/9/2017
BioAmber Announces Underwritten Offering Of Common Stock And Warrants 8/8/2017
The 1 Word In GW Pharma (GWPH)'s Q3 Update That Disappointed Investors 8/8/2017
BioAmber Announces US$11 Million Underwritten Offering Of Common Stock And Warrants 8/8/2017
Innate Pharma (IPH.PA ): Number Of Shares And Voting Rights Of Innate Pharma As At August 4, 2017 8/8/2017
Novadaq Announces Voting Results Of Special Meeting Of Shareholders 8/7/2017
VANC Pharmaceuticals Closed First Tranche Of Non Brokered Private Placement 8/7/2017
Teva (TEVA) Shares Are Getting Obliterated Again After Vicious Investment Bank Downgrades 8/7/2017
Galmed Pharmaceuticals Announces Pricing Of Offering Of Ordinary Shares To Existing Investors And Members Of The Board Of Directors 8/4/2017
Lonza Group (LZAGY.US) Prices EUR 700 Million And USD 200 Million Multi Tranche "Schuldschein" Loan 8/4/2017
AstraZeneca PLC (AZN): Buy The Dip? 8/4/2017
Isodiol International July 2017 Corporate Update 8/4/2017
Why You Want to Keep This Small $2 Biotech Stock On Your Radar 8/3/2017
Teva: Walking Dead?—Alternative Model 8/3/2017
Isodiol International Announces OTC Symbol Change 8/3/2017
Zealand Pharma  (ZEAL.CO) Commences Initial Public Offering Of American Depositary Shares In The United States 8/2/2017
Oriola Corporation - Repurchase Of Own Shares On 2 August 2017 8/2/2017
VANC Pharmaceuticals Provides Corporate Update 8/2/2017
146,000 Orion Corporation A Shares Converted Into B Shares 8/1/2017
China's Top 10 Pharmaceutical Companies 7/31/2017
Passing Of Zealand Pharma  (ZEAL.CO) Extraordinary General Meeting On 31 July 2017 7/31/2017
Vilacto Bio (QB.VIBI) Expands Its Exposure In Asia 7/31/2017
Ossur Hf : Transactions In Relation To Share Buyback Program 7/31/2017
Sanofi (SNY) Raises FY 2017 Business EPS Guidance To Broadly Stable At CER 7/31/2017
Neovacs : Successfully Raises €6.0 Million In Private Placement With U.S. Biotechnology Institutional Investors 7/31/2017
NicOx SA (COX.PA) : Ordinary Shareholder Meeting Of August 21, 2017 7/31/2017
Summit Therapeutics : Total Voting Rights 7/31/2017
Novo Nordisk A/S (NVO) - Share Repurchase Programme 7/31/2017
ProMis Neurosciences Announces Results Of Annual Meeting Of Shareholders 7/31/2017
Some GlaxoSmithKline (GSK) Critics Would Prefer Walmsley Broke Up the Company 7/28/2017
Kamada (KMDA) Announces Pricing Of Public Offering Of Ordinary Shares 7/28/2017
Nexvet Rule 17(d) Announcement 7/28/2017
Kamada (KMDA) Announces Proposed Public Offering Of Ordinary Shares 7/28/2017
Bavarian Nordic (BAVA.CO) Announces Additional Details Regarding The Issue Of Shares To Johnson & Johnson Innovation - JJDC 7/27/2017
China Cord Blood Files Its Annual Report On Form 20-F 7/26/2017
Protalix (PLX) Completes Private Note Exchange Of $9 Million Notes Maturing September 2018 For $8.55 Million Notes Maturing February 2022 7/26/2017
Lonza Inc. Pharma&Biotech Launches Ibex Solutions – An Innovative New Concept In Biological Manufacturing And Development 7/26/2017
Kane Biotech Inc. (KNE) Announces Removal Of All Debt From Its Balance Sheet And Grant Of Options 7/25/2017
Ipsen (IPN.PA): Disclosure Of Transactions In Own Shares Between 17/07/2017 And 21/07/2017 7/25/2017
Conversion Of FIT Biotech's Convertible Capital Notes Into Shares 7/25/2017
e-Therapeutics' New CEO Takes The Ax To Four Drug Discovery Programs 7/24/2017
The Key To Bedfont Scientific's International Success 7/24/2017
Genetic Technologies Limited (GTG.AX) Receives Nasdaq Deficiency Notice 7/24/2017
ESSA Pharma Provides Further Update On Proposed Equity Offering 7/24/2017
Tetra Bio-Pharma (TBP) Accelerates Growth Strategy With Appointment Of Bernard Fortier As CEO 7/24/2017
Easton Pharmaceuticals (OP: EAPH) Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman's Diagnostics And Treatment Segment 7/24/2017
Coloplast (COLOB.CO) Release: Share Buy-Back Week 29/2017 7/24/2017
Novo Nordisk A/S (NVO) - Share Repurchase Programme 7/24/2017
Ablynx (ABLYF) Announces Warrant Exercise 7/24/2017
Uncertainty Hits as Roche (RHHBY) is Dealt Multiple Clinical Trial Setbacks 7/21/2017
Clariant : White Tale Holdings Increased Stake Above 10 Percent 7/20/2017
3 Big Pharmas That Give Investors the Biggest Bang for the Buck 7/20/2017
Zecotek Photonics Inc. Announces Non-Brokered Private Placement 7/19/2017
Vernalis PLC (VNLPY.PK): Year-End Trading Update And Notice Of Full Year Results 7/19/2017
Summit Therapeutics: Grant Of Share Options and Restricted Stock Units 7/19/2017
Cerulean (CERU) And DARÉ Bioscience Announce Closing And New Stock Symbol, "DARE" 7/19/2017
Ipsen (IPN.PA): Disclosure Of Transactions In Own Shares Between 10/07/2017 And 14/07/2017 7/18/2017
ESSA Pharma Announces Update To Proposed Equity Offering 7/18/2017
Forward Pharma (FWP) Announces Planned Distribution Of EUR 19.45 Per Share To Shareholders 7/18/2017
Summit Therapeutics: Result Of AGM 7/18/2017
NicOx SA (COX.PA): Number Of Voting Rights As Of July 17, 2017 7/18/2017
Midatech: Trading Update And Notice Of Results 7/18/2017
Allergy Therapeutics: Trading Update 7/18/2017
Amicus (FOLD) Announces Closing Of Underwritten Offering Of Common Stock And Full Exercise Of Option To Purchase Additional Shares 7/18/2017
BGI Genomics Climbs 44% After $81 Million Shenzhen IPO 7/17/2017
GeneNews (GEN.TO) Announces Extension Of Warrant Exercise Incentive Program 7/17/2017
GeneNews (GEN.TO) Announces Issuance Of Common Shares In Lieu Of Cash Payments To Participating Members Of Its Board Of Directors 7/17/2017
Targovax ASA: Final Result Of The Subsequent Offering 7/17/2017
Targovax: Last Day Of The Subscription Period In The Subsequent Offering 7/14/2017
BGI Genomics Completes $250 Million IPO On Shenzhen ChiNext 7/14/2017
After Its Drop, Is Aurinia (AUPH) Stock Now A Buy? 7/13/2017
Valeant (VRX) Announces Redemption Of Remaining Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.75% Senior Notes Due 2018 7/13/2017



//-->